Last $3.32 USD
Change Today +0.03 / 0.91%
Volume 141.3K
STXS On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 07/10/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Karl-Heinz Kuck M.D., Ph.D.

Member of Scientific Advisory Board, Stereotaxis Inc.
AgeTotal Calculated CompensationThis person is connected to 80 board members in 6 different organizations across 5 different industries.

See Board Relationships
62--

Background*

Dr. Karl-Heinz Kuck, M.D., Ph.D., serves as a Director of Cardiology at Allegemienes Krankenhaus St. Georg, Hamburg, Germany. Dr. Kuck has served the Head of the 2nd Medical Department (Cardiology) of the St. Georg Hospital in Hamburg, Germany since September 1, 1994. Dr. Kuck has served as the Temporary Head of the Department of Cardiology of the UHE in Hamburg, Germany since June 1, 1992 and Assistant Professor at the Department of Cardiology of the UHE in Hamburg, ...

Read Full Background

Corporate Headquarters*

4320 Forest Park Avenue
St. Louis, Missouri 63108

United States

Phone: 314-678-6100
Fax: 314-678-6159

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MD 1987
Universität zu Köln

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
STXS:US $3.32 USD +0.03

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Howard Zauberman Chief Executive Officer, President and Director
Vision-Sciences Inc.
$210.9K
Jeffrey M. Nugent Interim Chief Executive Officer, Director and Member of Finance Committee
BIOLASE, Inc.
--
Robert E. Kill Chairman, Chief Executive Officer and President
Uroplasty, Inc.
--
Daniel Goldberger Chief Executive Officer and Director
Bacterin International Holdings, Inc.
$143.1K
David M. Hable Chief Executive Officer, President and Director
Synergetics USA, Inc.
$410.8K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STEREOTAXIS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.